TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Classification accuracy of miRNA signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise-specific self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Control competence for physical training
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean DLQI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: week 14 fistula response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: week 14 composite remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: week 54 composite remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of vasopressor administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 6-month PAID total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 12-month PAID total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-month social burden
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: prevalence of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time-to-discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total Annualized Bleeding Rate (ABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean incremental recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first sustained gain of 15 letters or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first sustained absence of retinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first sustained absence of intraretinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increase in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of postoperative constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of enema rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility of the SPRINTT nutrition intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Vasomotor bothersomeness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vasomotor interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with body and facial features
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: dysbiosis of urogenital microflora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathological vaginal discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEP increase in ipsilesional M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iSP duration decrease in ipsilesional M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper limb score correlation with tDCS-induced increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of symptomatic hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Requirement for intravenous calcium administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of bouts of high-pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total percentage of complications
Endpoint domain: Adverse events/effects
Primary endpoint: numeric rating scale pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: motor symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: overall disease severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to first mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: catheter dysfunction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose infusion rate (GIR) to maintain euglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: initial migration pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implant stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of PCPs reporting routine M-CHAT screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion using the M-CHAT-R/F follow-up interview questions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Self-efficacy regarding ASD care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: late neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: binocular logMAR UNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular logMAR DCNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preferred reading distance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: combined risk of cardiovascular death or worsening heart failure events
Endpoint domain: Mortality/survival
Primary endpoint: incident melanoma risk
Endpoint domain: Mortality/survival
Primary endpoint: Noise disturbance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of maternal mastitis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of infant hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: YBOCS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of resuscitation during infant CPR simulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean GSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Abdominal distention frequency
Endpoint domain: Adverse events/effects
Primary endpoint: adverse events associated with biologic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Early marriage
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean visual acuity (VA) score at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of scar development at 2 years
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of sites with BOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: alcohol-related cigarette craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative, lead-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: ICD site pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subsequent exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of interpretable fetal heart rate tracing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of macrosomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cord blood insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative time to regain consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of regaining consciousness in 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mPI (modified Plaque Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mGI (modified Gingival Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABCA1-labeled exosomal miR-193b levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment retention
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: mean procedure time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: inadequate biochemical response to UDCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marked improvement in mMASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of DCNN models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of DCNN models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of respiratory events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Consumption of rescue analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 12-month cumulative incidence of major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in hypoglycemic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil count nadir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Severity of local site reactions (LSRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy measures maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival rates of SMART sealants
Endpoint domain: Mortality/survival
Primary endpoint: SCASS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: optimisation of heart failure diagnosis and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 12-month HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean number of antiglaucoma drugs used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Complete Spontaneous Bowel Movements (CSBMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bone Metastasis-Free Survival (BMFS)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in PI-MBS at week 12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in urge urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in total incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of patients achieving ≥75% reduction in urge urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: microbiological evaluability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: occurrence of postoperative SH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of recurrent thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Acute normalisation of pump power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from thrombosis at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Maternal serum retinol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of syndecan‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: risk of stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of incisional surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: time to major adverse cardiac events (MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Adjusted interobserver reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted intraobserver reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESS normalization
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Functional levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sex hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cost savings per patient year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cost per quality-adjusted life year (QALY)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean bone surface area fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median mature collagen area fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median blood vessel count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of ANC clinics to deliver ISTp‐DP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC concentrations of DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RBC concentrations of DPA n-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Seroconversion rates following vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean SARS-CoV2 IgG Ab titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AR and GR phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: catheter detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scan interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with events
Endpoint domain: Adverse events/effects
Primary endpoint: Skin density improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in prejowl sulci and nasolabial fold volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in enlarged pores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Latencies to smoke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of lunchtime daily energy needs consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-hour energy balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence according to MPR at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adherence as measured by SMAQ at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Persistence to therapy during the one-year period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cardiopulmonary benefits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in PANSS questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in cognitive function tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCI-C rating favoring PF-06412562
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased 25(OH)D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased depression severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: valid wears
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall scores in OSCE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of the standardised patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilator duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cost of extracapsular tonsillectomy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: median postoperative length of stay (pLOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: time to peristalsis recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in cardiac adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of IPN
Endpoint domain: Adverse events/effects
Primary endpoint: ECOG Performance Status (PS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of outpatient visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Average costs per visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total difficulties score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in proton density fat fraction of ≥30% by week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Physical Component Summary (PCS) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Discontinuation rates due to abnormal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: T25FW time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hemodynamically significant patent ductus arteriosus (hsPDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MST performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum culture conversion to negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average recall scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence about mask-wearing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: willingness to use a mask
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proximal tubulopathy
Endpoint domain: Adverse events/effects
Primary endpoint: rate of clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in serum C-reactive protein (CRP), ferritin and D-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal association between vitamin D levels and ankylosing spondylitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MAAS global score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dental treatment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in MMD at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: culture positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Counter-regulatory hormones (glucagon and epinephrine levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: median T-PSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major coronary events (MCE)
Endpoint domain: Mortality/survival
Primary endpoint: Client satisfaction with treatment assignment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adjusted NIRS readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical functioning domain of HRQoL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Social capital score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: proportion of arachidonic acid in plasma phospholipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: disposition index (DI30)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum high‐sensitive c‐reactive protein (hs‐CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of clinical symptoms of the bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of excessive gestational weight gain (eGWG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first and third trimester FLI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: third trimester allopregnanolone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes